| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198111193052102 |
| P698 | PubMed publication ID | 6270556 |
| P2093 | author name string | Blaese RM | |
| Tosato G | |||
| Steinberg AD | |||
| P2860 | cites work | Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis | Q24632165 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| cell function | Q95674809 | ||
| P304 | page(s) | 1238-1243 | |
| P577 | publication date | 1981-11-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Defective EBV-specific suppressor T-cell function in rheumatoid arthritis | |
| P478 | volume | 305 |
| Q33555983 | Abnormal responses of rheumatoid arthritis lymphocytes to Epstein-Barr virus infection in vitro: evidence for multiple defects |
| Q45806475 | Abnormal responsiveness of rheumatoid B cells to Epstein-Barr virus infection in vitro |
| Q35209798 | Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis |
| Q40109999 | Acquired Immune Deficiency Syndrome, Leading to Opportunistic Infections, Kaposi's Sarcoma, and Other MalignanciesVolume 20, Issue 3 |
| Q40147661 | Adoptively transferred anti-idiotype pulsed B cells mediate autoimmune myocarditis. |
| Q36347266 | Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation |
| Q69125116 | Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1 |
| Q45799164 | Antibodies to EB virus- and cytomegalovirus-induced antigens in early rheumatoid disease |
| Q69887590 | Antibodies to rheumatoid arthritis nuclear antigen (RANA) in Japanese patients with rheumatoid arthritis |
| Q33789445 | Antiviral immune responses: triggers of or triggered by autoimmunity? |
| Q40062446 | Autoanti-idiotypes exhibit mimicry of myocyte antigens in virus-induced myocarditis. |
| Q40104710 | Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine |
| Q35885043 | Autoimmune diseases: immunopathology and etiopathogenesis |
| Q39284653 | B cell clones in rheumatoid arthritis |
| Q72799673 | Biphasic changes of the immunological reactivity in the course of experimental lectin-induced arthritis of rabbits |
| Q21296711 | CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis |
| Q39728083 | Cell-mediated immunity in rheumatic disease |
| Q40114508 | Cellular immune function in rheumatic disease |
| Q70480436 | Changes in immunoregulatory lymphocyte populations in patients with histoplasmosis |
| Q72773019 | Characterisation of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid alpha-naphthyl esterase staining |
| Q43900165 | Circulating activated B cells in primary biliary cirrhosis |
| Q93139625 | Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders |
| Q41858036 | Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report |
| Q70985249 | Correlation of antibody to rheumatoid arthritis associated nuclear antigen and immune complexes to disease activity in patients with rheumatoid arthritis |
| Q33557368 | Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis |
| Q33556764 | Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis |
| Q35549449 | Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis |
| Q33556770 | Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis |
| Q45806341 | Defective rheumatoid lymphocyte function assessed by Epstein-Barr virus infection in vitro. |
| Q41157263 | Deficient control of in vitro Epstein-Barr virus infection in patients with ankylosing spondylitis |
| Q41201716 | Demonstration of impaired T cell regulation of Epstein-Barr virus stimulated B lymphocytes in rheumatoid arthritis with HLA identical, disease discordant sibling pairs |
| Q42125132 | Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain |
| Q34247347 | Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. Functional role in antigen-specific and allogeneic T cell recognition |
| Q35834701 | Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis |
| Q34162418 | Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: a quantitative study |
| Q44704053 | Effective anti-viral therapy for hemophagocytic syndrome associated with B-cell lymphoma |
| Q45798085 | Effects of cyclosporin A on immunoglobulin production by EB virus stimulated lymphocytes |
| Q70210213 | Epstein-Barr virus and rheumatoid arthritis |
| Q38211091 | Epstein-Barr virus and rheumatoid arthritis: cellular and molecular aspects |
| Q34896078 | Epstein-Barr virus and rheumatoid arthritis: is there a link? |
| Q26830464 | Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation |
| Q34058760 | Epstein-Barr virus induces erosive arthritis in humanized mice |
| Q39204638 | Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis |
| Q39494552 | Epstein-Barr virus infection and immunoregulation in man. |
| Q60303702 | Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis |
| Q36543431 | Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women |
| Q34719669 | Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease |
| Q43864016 | Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients |
| Q35914342 | Epstein-barr virus: environmental trigger of multiple sclerosis? |
| Q45723607 | Epstein‐Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real‐time polymerase chain reaction |
| Q39493656 | Etiology of rheumatoid arthritis |
| Q33557102 | Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis |
| Q35199901 | HLA-DR genotype risks in seropositive rheumatoid arthritis. |
| Q47549698 | Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis. |
| Q72771256 | Immune regulation in myasthenia gravis: Evidence for an increased suppressor T-cell population |
| Q92186275 | Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients |
| Q72535169 | Immunization and cot deaths |
| Q71209309 | Immunoglobulin secretion in human disease states |
| Q40118372 | Immunologic Effects of Nonsteroidal Anti-Inflammatory Drugs |
| Q39476821 | Immunologic effects of nonsteroidal anti-inflammatory agents. |
| Q39102806 | Impaired late suppression of Epstein-Barr virus (EBV)-induced immunoglobulin synthesis: a common feature of autoimmune disease |
| Q41656686 | In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin. |
| Q47346714 | Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: the mechanism of action |
| Q36943860 | Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. |
| Q45797856 | Increased responsiveness of rheumatoid B lymphocytes to stimulation by epstein-barr virus |
| Q72804142 | Induction of Suppressor Cell Activity by Human Pregnancy Serum |
| Q56452548 | Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis |
| Q40134528 | Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test |
| Q36281132 | Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study |
| Q43829965 | Long-term remission of an EBV-positive B cell lymphoproliferative disorder associated with rheumatoid arthritis under methotrexate with anti-CD20 monoclonal antibody (Rituximab) monotherapy. |
| Q26776151 | Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders |
| Q40213133 | Mechanism of action of nonsteroidal anti-inflammatory agents. |
| Q64047696 | Primary ovarian large B-cell lymphoma in patient with juvenile rheumatoid arthritis treated with low dose Methotrexate |
| Q40092521 | Regulation of the immune response by prostaglandins |
| Q45053715 | Regulatory roles of human OKT4/OKT8 subsets in polyclonal immunoglobulin production induced by herpes simplex type 1 virus |
| Q34578024 | Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen |
| Q72535172 | Rheumatoid lymphocyte defect revealed by cyclosporin A |
| Q39878813 | Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient |
| Q72939634 | Suppressor T-cell function in man: Suppression of immunoglobulin production by the direct action of immunoregulatory T cells on the B cell in four separate, distinct systems |
| Q45748463 | Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope |
| Q41356915 | Synovial fluid mononuclear cells exhibit a spontaneous HLA-DR driven proliferative response |
| Q33560806 | T cell cytotoxicity to Epstein-Barr virus infected B cells: comparison of patients with rheumatoid arthritis and their HLA identical siblings |
| Q36367545 | T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis |
| Q72800983 | T-Cell Immunoregulatory Functions in Rheumatoid Arthritis Patients |
| Q40951367 | The Epstein-Barr virus in autoimmunity |
| Q33557056 | The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies |
| Q69992834 | The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells |
| Q44277311 | The role of Ia positive T cells in patients with rheumatoid arthritis |
Search more.